Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Chinese Academy of Medical Sciences Hematology Hospital, Tianjin, Tianjin Municipality